Caveolin-1 Regulating the Invasion and Expression of Matrix Metalloproteinase (MMPs) in Pancreatic Carcinoma Cells

Journal of Surgical Research

Volumn 159, Issue 1, 2010, Pages 443-450

  Han, Fei ^a   Zhu, Hong Guang ^b,c  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

caveolin 1; matrix metalloproteinase; pancreatic carcinoma

Indexed keywords

CAVEOLIN 1; GELATIN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CARCINOMA; CAVEOLIN 1; CELL LINE, TUMOR; CHROMONES; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MORPHOLINES; NEOPLASM INVASIVENESS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 77049096710     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.03.079     Document Type: Article

References (29)

1. Kuniyasu H., Ellis L.M., Evans D.B., et al. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. Clin Cancer Res 5 (1999) 25
2. Koshiba T., Hosotani R., Wada M., et al. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 82 (1998) 642
3. Couet J., Belanger M.M., Roussel E., et al. Cell biology of caveolae and caveolin. Adv Drug Deliv Rev 49 (2001) 223
4. Liu P., Rudick M., and Anderson R.G. Multiple functions of caveolin-1. J Biol Chem 277 (2002) 41295
5. Williams T.M., and Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288 (2005) C494
6. Schwab W., Harada H., Goetz W., et al. Immunocytochemical and biochemical detection of EMMPRIN in the rat tooth germ: Differentiation-dependent co-expression with MMPs and co-localization with caveolin-1 in membrane rafts of dental epithelial cells. Histochem Cell Biol 128 (2007) 195
7. Tang W., and Hemler M.E. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. J Biol Chem 279 (2004) 11112
8. Gu D., Li H., Wang Z., et al. Caveolin-1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFR-MAPKs signaling pathway. Laryngoscope 117 (2007) 1782
9. Sunaga N., Miyajima K., Suzuki M., et al. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res 64 (2004) 4277
10. Kondapaka S.B., Fridman R., and Reddy K.B. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer 70 (1997) 722
11. Bender F.C., Reymond M.A., Bron C., et al. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60 (2000) 5870
12. Sloan E.K., Stanley K.L., and Anderson R.L. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23 (2004) 7893
13. Wiechen K., Diatchenko L., Agoulnik A., et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159 (2001) 1635
14. Wiechen K., Sers C., Agoulnik A., et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158 (2001) 833
15. Yang G., Truong L.D., Wheeler T.M., et al. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res 59 (1999) 5719
16. Suzuoki M., Miyamoto M., Kato K., et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 87 (2002) 1140
17. Lin M., DiVito M.M., Merajver S.D., et al. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer 4 (2005) 21
18. Haq M., Shafii A., Zervos E.E., et al. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer. Cancer Res 60 (2000) 3207
19. Jimenez R.E., Hartwig W., Antoniu B.A., et al. Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: An additive strategy for cancer control. Ann Surg 231 (2000) 644
20. Zervos E.E., Shafii A.E., and Rosemurgy A.S. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer. J Surg Res 81 (1999) 65
21. Bramhall S.R., Neoptolemos J.P., Stamp G.W., et al. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol 182 (1997) 347
22. Williams T.M., Medina F., Badano I., et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279 (2004) 51630
23. Chow A.K., Cena J., El-Yazbi A.F., et al. Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart. J Mol Cell Cardiol 42 (2007) 896
24. Reddy K.B., Krueger J.S., Kondapaka S.B., et al. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 82 (1999) 268
25. Liu J.F., Crepin M., Liu J.M., et al. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293 (2002) 1174
26. Suyama K., Shapiro I., Guttman M., et al. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2 (2002) 301
27. Janknecht R., Ernst W.H., Pingoud V., et al. Activation of ternary complex factor Elk-1 by MAP kinases. Embo J 12 (1993) 5097
28. Kortenjann M., Thomae O., and Shaw P.E. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2. Mol Cell Biol 14 (1994) 4815
29. Marais R., Wynne J., and Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73 (1993) 381